Biocon confident of accelerated growth in FY22: Kiran Mazumdar-Shaw
Posted by
www.biotecnika.org
Biocon's Executive Chairperson Kiran Mazumdar-Shaw on the company's
plans for fresh capital infusion in Biocon Biologics, growth
opportunities in the next fiscal and why India needs to speed up covid
vaccination.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/expect-accelerated-growth-from-next-fiscal-says-kiran-mazumdar-shaw/articleshow/80442315.cms
Subscribe to:
Post Comments (Atom)
Post a Comment